Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.
about
Modular Approach to Select Bacteriophages Targeting Pseudomonas aeruginosa for Their Application to Children Suffering With Cystic FibrosisSequencing and characterization of Pseudomonas aeruginosa phage JG004.Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum mediumCharacterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm.Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Côte d'Ivoire.Complete Genome Sequence of Pseudomonas aeruginosa Phage vB_PaeM_CEB_DP1Phage fitness may help predict phage therapy efficacy.Characterization of Pseudomonas aeruginosa phage K5 genome and identification of its receptor related genes.Characterization of Pseudomonas aeruginosa Phage C11 and Identification of Host Genes Required for Virion MaturationSynergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms.Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.Small Colony Variants and Single Nucleotide Variations in Pf1 Region of PB1 Phage-Resistant Pseudomonas aeruginosaGenomic and proteomic analyses of the terminally redundant genome of the Pseudomonas aeruginosa phage PaP1: establishment of genus PaP1-like phagesAnalyses of Short-Term Antagonistic Evolution of Pseudomonas aeruginosa Strain PAO1 and Phage KPP22 (Myoviridae Family, PB1-Like Virus Genus)Characterization of bacteriophages infecting clinical isolates of Pseudomonas aeruginosa stored in a culture collection.Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide.Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.A Genotypic Analysis of Five P. aeruginosa Strains after Biofilm Infection by Phages Targeting Different Cell Surface Receptors.Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent.A virulent phage JHP against Pseudomonas aeruginosa showed infectivity against multiple genera.Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans.Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions.Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.PB1-Like Phages: Whole Genomes from Metagenomes Offer Insight into an Abundant Group of Bacteriophages
P2860
Q28076246-8DF39EA2-4EB3-4171-A00B-C24634D329D6Q33899228-561F04E1-2EF4-4FEE-95C5-1EC5FEB76A15Q34860393-DA003CB2-9AAF-4FA7-8FDF-EB307E4EAA07Q35634231-ABDBC8BA-8BCB-4CA6-A54F-D036EC11AD80Q35675668-0E8911BC-0FE9-4D38-9100-1A73046B8C1DQ36091808-D7BE630D-E6E3-4C3E-AE84-51BFAEAF4BE9Q36110277-CD57C51C-1B2E-44E8-81C8-CBA319253DEDQ36134756-8356C965-4039-4EE1-8393-DF0CC3863F00Q36230120-50A0F50B-A5FC-4AC5-A1FE-2E9CA662E1ACQ36246210-8FDA276F-104B-4385-A2BB-F5A7DE962206Q36317480-A3CC4546-54EF-4778-A52A-704FAF7813E9Q36586859-F72BF809-3365-4E3C-944D-60E576DDEE17Q36665622-3AD4F4F9-97F5-43A9-8843-3CD3840DF7BEQ36840401-20A04C4D-571D-4E8B-8123-9A13EE539370Q37173625-8A0FD435-0798-435E-B856-219290325838Q37371517-A99C9803-C5EC-4FD2-8941-FB96CCB7D613Q37891784-D6FAC90A-4C88-4997-B485-A6EF8225872AQ37984505-20F46C7C-FF51-4AAD-A8DD-889E48E5D94EQ40058358-0B2C44CE-9E6C-41DD-BD26-222A19D6746DQ40120799-2D8E06DA-0950-489A-A90D-8DCA178F2A75Q40499136-7156EACA-1F08-4595-9589-EF4B5742AC35Q40785476-A23C9891-259E-46C8-8B0F-FC87748A3242Q41886330-1105C178-FDEC-4A6B-BBAB-8CC62ED66826Q47150323-5495C777-78EE-4A01-B696-994562A812ACQ51569454-8D0485CE-C1A2-492A-A682-24041D1DBC29Q54205022-0394DB7A-D7BE-47A7-8026-C0422F596B74Q57015033-075AF887-F566-4E62-AC72-D3F697003BDF
P2860
Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of JG024, a p ...... imulated infection conditions.
@ast
Characterization of JG024, a p ...... imulated infection conditions.
@en
type
label
Characterization of JG024, a p ...... imulated infection conditions.
@ast
Characterization of JG024, a p ...... imulated infection conditions.
@en
prefLabel
Characterization of JG024, a p ...... imulated infection conditions.
@ast
Characterization of JG024, a p ...... imulated infection conditions.
@en
P2093
P2860
P356
P1433
P1476
Characterization of JG024, a p ...... simulated infection conditions
@en
P2093
Andrea Wesche
Christine Rohde
Johannes Sikorski
Julia Garbe
Katherina Selezska
Manfred Rohde
Marlon Kazmierczak
Max Schobert
P2860
P2888
P356
10.1186/1471-2180-10-301
P577
2010-11-26T00:00:00Z